| Cancer-related molecular mechanisms research | Lifetime | 27 | CN 10 | 99.77 |
| Circular RNAs in diseases | Lifetime | 10 | CN 3 | 99.81 |
| MicroRNA in disease regulation | Lifetime | 20 | CN 3 | 99.85 |
| Birth, Development, and Health | Lifetime | 38 | CN 1 | 99.80 |
| Pregnancy and preeclampsia studies | Lifetime | 26 | CN 1 | 99.75 |
| Epigenetics and DNA Methylation | Lifetime | 84 | CN 4 | 99.68 |
| Cell Adhesion Molecules Research | Lifetime | 121 | CN 2 | 99.48 |
| RNA modifications and cancer | Lifetime | 236 | CN 23 | 99.39 |
| Nitric Oxide and Endothelin Effects | Lifetime | 93 | CN 2 | 99.51 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 119 | CN 3 | 99.39 |
| Autophagy in Disease and Therapy | Lifetime | 76 | CN 7 | 99.45 |
| Receptor Mechanisms and Signaling | Lifetime | 176 | CN 3 | 99.40 |
| Mitochondrial Function and Pathology | Lifetime | 195 | CN 5 | 99.18 |
| Cardiac Ischemia and Reperfusion | Lifetime | 83 | CN 2 | 99.20 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 388 | CN 19 | 98.87 |
| Adipose Tissue and Metabolism | Lifetime | 365 | CN 10 | 99.05 |
| Reproductive System and Pregnancy | Lifetime | 200 | CN 10 | 98.68 |
| Ion channel regulation and function | Lifetime | 318 | CN 8 | 98.88 |
| Neonatal Respiratory Health Research | Lifetime | 419 | CN 1 | 98.80 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 56 | CN 6 | 98.43 |
| Neonatal and fetal brain pathology | Lifetime | 159 | CN 7 | 98.78 |
| Anesthesia and Neurotoxicity Research | Lifetime | 215 | CN 12 | 98.39 |
| Neuroscience of respiration and sleep | Lifetime | 329 | CN 9 | 98.44 |
| Biochemical effects in animals | Lifetime | 217 | CN 15 | 98.18 |
| Cell death mechanisms and regulation | Lifetime | 215 | CN 12 | 98.24 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 199 | CN 11 | 98.25 |
| Cancer-related gene regulation | Lifetime | 427 | CN 45 | 97.85 |
| Immune Response and Inflammation | Lifetime | 721 | CN 22 | 98.30 |
| Renin-Angiotensin System Studies | Lifetime | 166 | CN 2 | 98.08 |
| Peptidase Inhibition and Analysis | Lifetime | 879 | CN 27 | 97.29 |
| Congenital heart defects research | Lifetime | 357 | CN 6 | 97.24 |
| Gestational Diabetes Research and Management | Lifetime | 408 | CN 8 | 97.50 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 496 | CN 10 | 96.77 |
| Neuropeptides and Animal Physiology | Lifetime | 945 | CN 22 | 97.18 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 374 | CN 9 | 96.79 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 667 | CN 71 | 96.64 |
| Cannabis and Cannabinoid Research | Lifetime | 471 | CN 4 | 96.58 |
| Hormonal Regulation and Hypertension | Lifetime | 860 | CN 14 | 96.76 |
| Protease and Inhibitor Mechanisms | Lifetime | 612 | CN 10 | 96.52 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 432 | CN 8 | 97.05 |
| Calpain Protease Function and Regulation | Lifetime | 86 | CN 2 | 95.15 |
| Pharmacological Effects of Natural Compounds | Lifetime | 859 | CN 230 | 95.21 |
| Apelin-related biomedical research | Lifetime | 185 | CN 7 | 94.71 |
| Cardiovascular Issues in Pregnancy | Lifetime | 590 | CN 5 | 95.79 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 801 | CN 23 | 96.32 |
| Nicotinic Acetylcholine Receptors Study | Lifetime | 562 | CN 6 | 95.76 |
| High Altitude and Hypoxia | Lifetime | 400 | CN 9 | 95.30 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 632 | CN 21 | 94.38 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 131 | CN 32 | 92.54 |
| Phagocytosis and Immune Regulation | Lifetime | 402 | CN 23 | 94.09 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 851 | CN 42 | 95.19 |
| Galectins and Cancer Biology | Lifetime | 860 | CN 25 | 93.47 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 356 | CN 17 | 93.32 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 996 | CN 99 | 93.18 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 791 | CN 35 | 93.23 |
| NF-κB Signaling Pathways | Lifetime | 924 | CN 65 | 92.97 |
| Hydrogen's biological and therapeutic effects | Lifetime | 185 | CN 46 | 89.71 |
| ATP Synthase and ATPases Research | Lifetime | 969 | CN 21 | 92.11 |
| Prenatal Substance Exposure Effects | Lifetime | 783 | CN 3 | 92.12 |
| Caveolin-1 and cellular processes | Lifetime | 578 | CN 18 | 87.52 |
| Calcium signaling and nucleotide metabolism | Lifetime | 667 | CN 37 | 88.41 |
| Protein Tyrosine Phosphatases | Lifetime | 810 | CN 73 | 87.22 |
| FOXO transcription factor regulation | Lifetime | 442 | CN 74 | 84.63 |
| Barrier Structure and Function Studies | Lifetime | 860 | CN 37 | 86.43 |
| Macrophage Migration Inhibitory Factor | Lifetime | 878 | CN 53 | 81.15 |
| Pregnancy and preeclampsia studies | 2021-2025 | 6 | CN 1 | 99.73 |
| Birth, Development, and Health | 2021-2025 | 9 | CN 2 | 99.50 |
| MicroRNA in disease regulation | 2021-2025 | 17 | CN 11 | 99.67 |
| Mitochondrial Function and Pathology | 2021-2025 | 14 | CN 2 | 99.16 |
| Circular RNAs in diseases | 2021-2025 | 14 | CN 10 | 99.50 |
| Autophagy in Disease and Therapy | 2021-2025 | 12 | CN 6 | 98.94 |
| Epigenetics and DNA Methylation | 2021-2025 | 38 | CN 17 | 98.75 |
| Cancer-related molecular mechanisms research | 2021-2025 | 55 | CN 37 | 99.43 |
| RNA modifications and cancer | 2021-2025 | 118 | CN 79 | 98.72 |
| Immune Response and Inflammation | 2021-2025 | 27 | CN 7 | 97.17 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 167 | CN 55 | 96.62 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 44 | CN 14 | 95.59 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 23 | CN 5 | 96.79 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 15 | CN 3 | 93.01 |
| Reproductive System and Pregnancy | 2021-2025 | 112 | CN 40 | 96.25 |
| Cancer-related gene regulation | 2021-2025 | 97 | CN 64 | 94.27 |
| Adipose Tissue and Metabolism | 2021-2025 | 217 | CN 46 | 94.90 |
| Neonatal Respiratory Health Research | 2021-2025 | 348 | CN 12 | 95.46 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 78 | CN 15 | 92.64 |
| Gestational Diabetes Research and Management | 2021-2025 | 188 | CN 20 | 94.65 |
| Biochemical effects in animals | 2021-2025 | 101 | CN 72 | 92.94 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 515 | CN 226 | 90.41 |
| Neonatal and fetal brain pathology | 2021-2025 | 224 | CN 13 | 93.37 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 194 | CN 23 | 91.22 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 82 | CN 38 | 87.34 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 90 | CN 21 | 87.75 |
| Inflammasome and immune disorders | 2021-2025 | 427 | CN 201 | 88.92 |
| Metabolism and Genetic Disorders | 2021-2025 | 368 | CN 22 | 87.75 |
| Maternal and fetal healthcare | 2021-2025 | 411 | CN 15 | 88.77 |
| Adenosine and Purinergic Signaling | 2021-2025 | 212 | CN 41 | 84.10 |
| Cell Adhesion Molecules Research | 2021-2025 | 334 | CN 42 | 81.73 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 144 | CN 30 | 83.30 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 941 | CN 66 | 83.00 |
| Peroxisome Proliferator-Activated Receptors | 2021-2025 | 210 | CN 66 | 80.14 |
| Ubiquitin and proteasome pathways | 2021-2025 | 930 | CN 399 | 81.70 |
| FOXO transcription factor regulation | 2021-2025 | 54 | CN 13 | 74.66 |
| School Health and Nursing Education | 2021-2025 | 192 | CN 6 | 77.62 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 804 | CN 159 | 77.88 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 537 | CN 92 | 77.56 |
| Plant and fungal interactions | 2021-2025 | 146 | CN 33 | 77.05 |
| Congenital Anomalies and Fetal Surgery | 2021-2025 | 652 | CN 98 | 73.44 |
| Pregnancy-related medical research | 2021-2025 | 658 | CN 56 | 70.91 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 892 | CN 124 | 69.40 |
| Fetal and Pediatric Neurological Disorders | 2021-2025 | 986 | CN 150 | 68.75 |
| Folate and B Vitamins Research | 2021-2025 | 995 | CN 270 | 66.23 |
| Barrier Structure and Function Studies | 2021-2025 | 369 | CN 82 | 65.90 |
| Preterm Birth and Chorioamnionitis | 2021-2025 | 698 | CN 59 | 63.80 |
| Healthcare and Venom Research | 2021-2025 | 527 | CN 157 | 63.49 |
| Tumors and Oncological Cases | 2021-2025 | 899 | CN 76 | 61.85 |
| Ion Channels and Receptors | 2021-2025 | 766 | CN 135 | 56.66 |
| Cell death mechanisms and regulation | 2021-2025 | 733 | CN 215 | 49.23 |
| GDF15 and Related Biomarkers | 2021-2025 | 747 | CN 129 | 48.85 |
| Hydrogen's biological and therapeutic effects | 2021-2025 | 533 | CN 257 | 39.72 |